Try a synonym, or sign up to suggest a template from the app.
BioRender Template
Bispecific Antibody Design
Creator
s
Description
This template was adapted from the original submission. Edits were made to enhance scientific accuracy, optimal usability and/or to meet industry-leading design standards for science communication.
(A) Illustrative representation of Blinatumomab, the only FDA approved bispecific antibody, designed to target CD3 (healthy T-cells) and CD19 (malignant hematologic tumors) through anti-CD3/CD19 single-chain variable fragments. (B) Mosunetuzumab, a bispecific antibody under clinical trial evaluation, is designed to target CD3 and CD20, where the CD20 targeting is achieved through the full-length domain of the antibody Fc domain.
Use this templateThis template is fully editable in BioRender with a free BioRender account — no credit card required to sign up.
Don’t start from scratch.
Create professional scientific illustrations quickly and easily, even without any design expertise
- Get started with a huge library of editable icons and templates such as common biological pathways, anatomy, or genetics.
- Create figures that effectively communicate your research in half the time using our editable icons.
- Use our PDB tool to quickly generate and customize protein structures.
.gif)
